After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Achillion Pharmaceuticals (ACHN) stock rating was increased this morning to 'market outperform' at JMP as the firm believes the company's factor D program is a 'game changer.'
Here are Thursday's top research calls, including an upgrade for Zions, and downgrades for First Solar, Qualcomm and Red Hat.
Trade-Ideas LLC identified Achillion Pharmaceuticals (ACHN) as a weak on high relative volume candidate
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.